Zoryve Cream Improves Sleep in Atopic Dermatitis Patients
New clinical data demonstrate Zoryve's effectiveness in treating atopic dermatitis, reducing sleep disruptions and maintaining disease control with minimal adverse events across all ages.
The use of Zoryve (roflumilast) cream improved quality of life, helping patients with atopic dermatitis to reduce sleep disruptions, according to data presented at the 2025 Fall Clinical Dermatology Conference in Las Vegas.
Additionally, new long-term data demonstrate that Zoryve cream was well-tolerated and provided continued disease control for patients who switched to twice-weekly treatment.
Sleep disruption is a persistent and often overlooked but very real daily burden for those impacted by atopic dermatitis, including young children and their families
— Mercedes E. Gonzalez, M.D.
Author's summary: Zoryve cream reduces sleep disruptions.
More News
- Trump speaks at the ceasefire signing between Cambodia and Thailand
- A Literacy Crisis? Spooky!
- Mayor Johnson’s record-setting $1 billion TIF surplus highlights issues and abuse of Chicago’s Tax Increment Financing districts
- In photos: Peckham Town climb to second place with 3-0 victory over Farnborough OBG, Sat 25th Oct 2025
- Garbage menace and irresponsible behaviour - Star of Mysore
- 'A House Of Dynamite' Ending Explained – Can The U.S. Stop A Nuclear Missile? What Decision Does The President Make? | Trending News Buzz
- To the Woman Who Walked So We Could Run - Nana Konadu Agyeman-Rawlings - MyJoyOnline
- Compulsory voting: A remedy or ruse for democracy? - Institute of Development Studies